PRE-OP H&P S: WHAT REALLY MATTERS

Size: px
Start display at page:

Download "PRE-OP H&P S: WHAT REALLY MATTERS"

Transcription

1 1 2 PRE-OP H&P S: WHAT REALLY MATTERS Jenikka Soyring, DNP Why Pre-op Assessments Reduce risk for cardiac, pulmonary and infectious complications Not meant to clear for surgery It is to evaluate and implement measures to prepare higher risk patients for surgery Factors Contributing to Risk Increase demand for surgery in older and sicker patients Functional decline Decreased ability to compensate for impaired function or increased physical demand Multiple comorbidities 3 Basics of what a surgeon needs Quality care Co-management of complex patients Communication (they want to focus on the surgical issue) Timely care 4 Potential Problems Disagreement with multiple opinions Lack of ownership Additional cost 5 What can the RN do? Make sure the H&P is complete Cardiac Renal Endocrine (DM) Pulmonary Home instructions are clear for pre-op 6 Post-discharge plans

2 7 8 What s Important? History What surgery Pt s experience with anesthesia Recent illness Cardiac Risk Assessment Evaluate risk for both pt and surgeon Optimize appropriate testing and intervention Clinical judgment PMH (heart and lungs), meds including OTCs Functional Assessment 9 10 Cardiac Risk Assessment Risk reduction Timing of surgery Anesthesia (MAC vs general) Medications Intervention Cardiac Timing of surgery Postop MI risk after recent MI: <30days ~33% risk days: ~18% days ~9% : ~5% >1 year: <2% Livhits, M. et al. Annals of Surgery, May Cardiac Anesthesia (regional vs general) Pros of regional Less myocardial, respiratory depression Avoid ET tube (autonomic stimulation) Cons of regional Anxiety myocardial oxygen consumption Spinal vasodilation decreased BP

3 13 14 Bottom line for cardiac Low risk: OK for surgery Elevated risk: METS >/=4 then OK for surgery Elevated risk: METS <4 then stress test Renal CKD Typically with multiple comorbidities Increased risk for major complications including cardiac Look for lab evaluation Fluid and electrolyte balance: EKG? Anemia Nutritional status Glucose Cardiac risk eval ESRD Nephrologist involved? Recent Echo Left ventricular dysfunction increases surgical M&M Dialysis Timing Elective: day before Emergency: can be pre-op Endocrine Diabetes Risk for wound infection, pneumonia, UTI, sepsis, ileus and mortality Type 1 or Type 2! Never stop insulin in type 1 Ketoacidosis in hospitalization mean no payment Hgb A1c level controversial <8.5% for elective surgery within my system Pulmonary Postop Pulmonary Complication (PPC) risk 5.8% Risk increases with type of surgery Close to diaphragm can decrease vital capacity by 50-60% Medications used Anesthetics, opioids decrease respiratory drive and cough reflex Neuromuscular blockers relax chest wall and diaphragm Pulmonary Smoking history Smoking cessation 4 weeks preop COPD and asthma Preop optimization inhaler use Meds Take meds day of surgery Pre and postop Lung expansion exercises

4 19 20 Perioperative Medications Limited data via clinical trials Wide variation Overall most meds are tolerated well with anesthesia General Med Rules Accurate complete list Are they taking their meds Individualize plan Co-morbidities, procedure, pharmacokinetics, withdrawal, interactions Communication Clearly written which meds to hold and for how long Antihypertensives Hold diuretics Volume depletion Electrolytes Individualize ACE/ARB General consensus Hold Continue beta blockers Decreased ischemia and prevents arrhythmias Increase risk of ischemia with withdrawal Generally continue all others 2014 ACC/AHA Guideline on perioperative cardiovascular eval Anticoagulants/Antiplatelet ASA Individualize. Bleeding risk vs thrombotic risk Increases risk of major bleeding 4.8% vs 3.8% without Hold 5-7 days before surgery Anticoagulants: look at half-life 5 to completely clear (Common practice. Always individualize) Coumadin: Stop 5 days before Clopidogrel (Plavix): stop 7 days in advance Prasugrel (Effient): stop 7-10 days in advance Apixaban (Eliquis): stop 2 days before surgery Rivaroxaban (Xarelto): Stop 2 days before surgery Anticoagulants--bridging Bridging (Lovenox or heparin) Individualize Unclear benefit, may harm Risk of thrombosis 0.4% vs 0.3% with bridging Risk of major bleeding 1.3% vs 3.2% with bridging Risk of minor bleeding 12% vs 20.9% with bridging ACCP 2012: CHADS 5-6, TIA/CVA within 3 months, Rheumatic valve disease ACC/AHA 2014: Mechanical heart valve, prior stroke, CHADS2-Vasc >=2 Other factors to consider: active cancer, VTE in last 12 weeks, severe thrombophilia (Factor V, etc) 23 Oral Diabetes Medications Hold all oral agents Risk for: Lactic acidosis Kidney injury Hypoglycemia Fluid retention Slowed gastric motility 24

5 25 26 Insulin NO short acting insulin while NPO Half NPH at usual time DMARDs Hold Hold 1-2 half lives preoperatively (Imuran, methotrexate, rituxan, plaquenil, humira, enbrel, etc) Long acting insulin: Half dose Case 1 89 yo F Toe amputation d/t osteo PMH: 34 on list cerebral infarction, CHF, CKD stage 3, HTN, DM 2, pulmonary htn, MI x2, uses CPAP Meds: 19 Imdur, Metoprolol, cozaar, Lasix, ASA 81 Case 1 What is your plan? Is she OK for surgery? METs 4 METs YES! Meds: Only take beta blocker Pulm: IS OSA: Monitor Labs: K 4.9, hgb 13, crt 1.06 EKG: Sinus, evidence old MI, No acute findings VS: 110/62, , 93%RA PE: WNL Case 2 79 yo M Sacral Nerve stimulator MAC PMH: TIA, HTN, Pacer, Afib, BPH, CPAP Meds: 26 Metoprolol, Lasix, Apixaban, ASA, finasteride Labs: hgb 14.2, K 4.6, Crt 0.74 VS 128/82, , 97% PE: Normal, Pacer L chest Meds: Eliquis stop 2 days before surgery, Stop ASA 1 week before, take all others why? Case 3 79 yo F Glossectomy d/t tongue cancer PMH: MI this year about 5 months ago with cardiac arrest-defibrillator, anemia, CHF EF 35% Meds: Metoprolol, synthroid, Iron, asa, sertraline, donepezil Dilaudid 4mgQ4H, tramadol 100mgBID, Lorazepam 1mgTID, Ambien 5mg, amitriptyline 50mg dulcolax, miralax, senokot, kids gummy vitamin VS: 112/64, , 96%RA

6 31 32 Case 3 PE: Cachectic, in a wheel chair, faint murmur Labs: WBC 1.7 hgb 8.9 (1mo ago 10.2) plt 85 K 3.7 crt 0.42 Albumin 3 Case 3 What do you do? Or what did I do? Nothing! Send to Cardiology! Given OK by Cards: Hold ASA about 5 days EKG: 100% V-paced (previously about 50% paced) Case 4 71 yo M Ischemic finger, amputation PMH: ESRD, DM 1, htn, PVD Meds: Lasix, Coreg, Plavix, Humalog pump, ASA 325 VS: 135/85, , 99% RA Surg Hx: Multiple toe amputations, AV Fistula placed 1 week ago Case 4 Labs K 4.8 Crt 6.39 Hgb A1C 8.7 Hgb 10 EKG: R BBB, unchanged from previous PE: R 5 th finger black distal phalanx, multiple scabs along dorsal aspect of finger Case 4 What did I do? Insulin cut basal dose by 25%. Why? Recent lower glucose Plavix Continue. Why? Embolic cause of ischemia and surgery just 1 week ago Lasix hold Questions? Thanks! Jenikkalee@gmail.com

4/27/2015. Cardiac Events #1 cause of postoperative complications/ mortality- CHF, complete heart block, MI,

4/27/2015. Cardiac Events #1 cause of postoperative complications/ mortality- CHF, complete heart block, MI, Not intended for medical clearance Identify, document, and evaluate health conditions Medication Management Stratify Risks Optimize conditions within context of surgical illness Recommend measures that

More information

PREOP EVALUATION AND OPTIMIZATION

PREOP EVALUATION AND OPTIMIZATION PREOP EVALUATION AND OPTIMIZATION Barry Perlman, PhD, MD System Lead, Anesthesia Physician Best Practice 4/2012 Disclosure of Potential Financial Conflicts of Interest None But am open to any and all offers

More information

Managing Perioperative Anticoagulation. Edie Shen MD

Managing Perioperative Anticoagulation. Edie Shen MD Managing Perioperative Anticoagulation Edie Shen MD Anticoagulation VKA Warfarin (Coumadin) DOACs Direct Thrombin Inhibitor Dabigatran (Pradaxa) Factor Xa Inhibitor Rivaroxaban(Xarelto) Apixaban(Eliquis)

More information

How to Address an Inappropriately high Mortality Rate? Joe Sharma, MD Associate Professor of Surgery NSQIP Surgical Champion

How to Address an Inappropriately high Mortality Rate? Joe Sharma, MD Associate Professor of Surgery NSQIP Surgical Champion How to Address an Inappropriately high Mortality Rate? Joe Sharma, MD Associate Professor of Surgery NSQIP Surgical Champion Disclosure Slide No COI and no disclosures. Hospital Mortality rate : is it

More information

Clinical Controversies in Perioperative Medicine

Clinical Controversies in Perioperative Medicine Update on Perioperative Medicine Clinical Controversies in Perioperative Medicine Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Cardiac Medications & Perioperative

More information

Asif Serajian DO FACC FSCAI

Asif Serajian DO FACC FSCAI Anticoagulation and Antiplatelet update: A case based approach Asif Serajian DO FACC FSCAI No disclosures relevant to this talk Objectives 1. Discuss the indication for antiplatelet therapy for cardiac

More information

A preoperative evaluation allows us to: learn about the patient. risk stratify them based on their comorbities

A preoperative evaluation allows us to: learn about the patient. risk stratify them based on their comorbities A preoperative evaluation allows us to: learn about the patient risk stratify them based on their comorbities assists in anesthesia preop, intraop and postoperative planning COMPONENTS OF A PREOP Thorough

More information

To Bridge or Not to Bridge? Preop Evaluation of the Patient on Coumadin

To Bridge or Not to Bridge? Preop Evaluation of the Patient on Coumadin To Bridge or Not to Bridge? Preop Evaluation of the Patient on Coumadin Omprakash Pansara, MD Brian Kline, MD St. Joseph s Health Family Medicine Residency Program, Syracuse, NY Case 75yr old male, who

More information

Preoperative Cardiac Evaluation:

Preoperative Cardiac Evaluation: Preoperative Cardiac Evaluation: The New Guidelines Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Disclosures No financial relationships with pharmaceutical

More information

Pre-operative Evaluations. Objectives. General Considerations. FP Consultation Considerations. CV Credits 7/24/2017. Brian Bachelder, MD Akron, Ohio

Pre-operative Evaluations. Objectives. General Considerations. FP Consultation Considerations. CV Credits 7/24/2017. Brian Bachelder, MD Akron, Ohio Pre-operative Evaluations Brian Bachelder, MD Akron, Ohio Objectives Discuss the perioperative cardiopulmonary evaluation and management of patients undergoing non-cardiac surgery Objectively estimate

More information

Clinical Controversies in Perioperative Medicine

Clinical Controversies in Perioperative Medicine Clinical Controversies in Perioperative Medicine Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Predicting & Managing Cardiac Risk A 70-y.o. man with progressive

More information

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Cardiac evaluation for the noncardiac patient Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Objectives! Review ACC / AHA guidelines as updated for 2009! Discuss new recommendations

More information

Prostate Biopsy Alerts

Prostate Biopsy Alerts Prostate Biopsy Alerts Saskatchewan Prostate Assessment Pathway Guidelines for the Primary Care Provider for Patient Preparation and the Management of Medications and Complications September 2016 Table

More information

Clinical Controversies in Perioperative Medicine

Clinical Controversies in Perioperative Medicine Clinical Controversies in Perioperative Medicine Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Cardiac Evaluation: New Guidelines A 70-y.o. man with progressive

More information

Atrial Fibrillation is Common. The (S)Low-down on Rapid Afib Resuscitation Step ED Dx - Rx 4/4/2017. There Are 5 Causes of Atrial Fibrillation

Atrial Fibrillation is Common. The (S)Low-down on Rapid Afib Resuscitation Step ED Dx - Rx 4/4/2017. There Are 5 Causes of Atrial Fibrillation The (S)Low-down on Rapid Afib Resuscitation 2017 Corey M. Slovis, M.D. Vanderbilt University Medical Center Metro Nashville Fire Department Nashville International Airport Nashville, TN Atrial Fibrillation

More information

Preoperative Evaluation Guidelines and Work up

Preoperative Evaluation Guidelines and Work up Preoperative Evaluation Guidelines and Work up Wesley Fiser, MD Disclosures: None 1 Case An 80 year old woman with osteoarthritis of the hip, DM, CKD (Cr 2.1), and HTN is diagnosed with an obstructing

More information

Disclosures. Overview. Have you ever. The Perioperative Management of Anticoagulants. No financial conflicts of interest to disclose

Disclosures. Overview. Have you ever. The Perioperative Management of Anticoagulants. No financial conflicts of interest to disclose Disclosures No financial conflicts of interest to disclose The Perioperative Management of Anticoagulants Margaret C. Fang, MD, MPH Associate Professor of Medicine UCSF Division of Hospital Medicine Medical

More information

Update in Perioperative Medicine

Update in Perioperative Medicine Update in Perioperative Medicine Linda Venner MD FACP March 2018 Agenda 1 2 3 4 5 Optimized not Cleared Identify red flags for cardiac and pulmonary complications Optimize management Prevent delirium Don

More information

Anesthesia Preoperative Patient History

Anesthesia Preoperative Patient History Anesthesia Preoperative Patient History Please Complete and BRING WITH YOU to Your Anesthesia Appointment Patient Name: Date of Birth: Phone Number: Kind of Surgery You are Having: Date of Your Surgery:

More information

3/23/2017. Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate Europace Oct;14(10): Epub 2012 Aug 24.

3/23/2017. Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate Europace Oct;14(10): Epub 2012 Aug 24. Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017 Explain the efficacy and safety of triple therapy, in regards to thromboembolic and bleeding risk Summarize the guideline recommendations

More information

Preoperative Cardiac Risk Assessment: Approach & Guidelines

Preoperative Cardiac Risk Assessment: Approach & Guidelines Preoperative Cardiac Risk Assessment: Approach & Guidelines By, Liam Morris, MD., FACC (02/03/18) CPG : Clinical Practice Guidelines GDMT : Guidelines Directed Medical Therapy GWC : Guideline Writing Committee

More information

Cardiac Risk Assessment in the Preoperative period

Cardiac Risk Assessment in the Preoperative period Cardiac Risk Assessment in the Preoperative period Catherine Curley, MD May, 2017 Disclosures I am not a cardiologist! 1 Case 1 78 yo man presenting to the ED after mechanical fall on his driveway. Found

More information

Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017

Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017 Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017 Explain the efficacy and safety of triple therapy, in regards to thromboembolic and bleeding risk Summarize the guideline recommendations

More information

Diagnosis Coding. Tips, Guidelines & Common Errors. Amy Jack, Risk Adjustment Coding Auditor, RHIT, CCA, CRC

Diagnosis Coding. Tips, Guidelines & Common Errors. Amy Jack, Risk Adjustment Coding Auditor, RHIT, CCA, CRC Diagnosis Coding Tips, Guidelines & Common Errors Amy Jack, Risk Adjustment Coding Auditor, RHIT, CCA, CRC Medical Coding Why is Diagnosis Coding Important? Protect Patient Health Ensure Quality Patient

More information

Controversies in Perioperative Medicine

Controversies in Perioperative Medicine Controversies in Perioperative Medicine Staying Abreast & Ahead of the Guidelines Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Controversies in Perioperative

More information

Preoperative Cardiac Risk Calculators

Preoperative Cardiac Risk Calculators The Fort Lauderdale, Florida Preoperative Cardiac Risk Calculators Steven L. Cohn, MD, FACP, SFHM Professor Emeritus Director - Medical Consultation Service Jackson Memorial Hospital University of Miami

More information

PRE-OPERATIVE EVALUATION AND MANAGEMENT FOR NON- CARDIAC SURGERY AN INTERNIST S PERSPECTIVE

PRE-OPERATIVE EVALUATION AND MANAGEMENT FOR NON- CARDIAC SURGERY AN INTERNIST S PERSPECTIVE PRE-OPERATIVE EVALUATION AND MANAGEMENT FOR NON- CARDIAC SURGERY AN INTERNIST S PERSPECTIVE 2018 EDITION Michael Tuchfarber, MD DISCLOSURES No financial or corporate disclosure Any brand names mentioned

More information

CCS Perioperative Guidelines When to order a BNP and What to do with a Positive Troponin

CCS Perioperative Guidelines When to order a BNP and What to do with a Positive Troponin Canadian Society of Internal Medicine Annual Meeting 2017 Toronto, ON CCS Perioperative Guidelines When to order a BNP and What to do with a Positive Troponin Dr. Vikas Tandon Associate Professor, Cardiology

More information

Non ST Elevation-ACS. Michael W. Cammarata, MD

Non ST Elevation-ACS. Michael W. Cammarata, MD Non ST Elevation-ACS Michael W. Cammarata, MD Case Presentation 65 year old man PMH: CAD s/p stent in 2008 HTN HLD Presents with chest pressure, substernally and radiating to the left arm and jaw, similar

More information

Clinical Controversies in Perioperative Medicine!

Clinical Controversies in Perioperative Medicine! Clinical Controversies in Perioperative Medicine! Hugo Quinny Cheng, MD! Division of Hospital Medicine! University of California, San Francisco! Disclosures! Perioperative beta-blockade & statin therapy

More information

2017 Bryan Health Primary Care Conference. Dale Hansen MD Bryan Heart 5/20/17

2017 Bryan Health Primary Care Conference. Dale Hansen MD Bryan Heart 5/20/17 2017 Bryan Health Primary Care Conference Dale Hansen MD Bryan Heart 5/20/17 I have no financial disclosures or conflicts of interest Bridging Anticoagulation Primum Non Nocere 67 y.o. male with mechanical

More information

Challenges in Perioperative Medication Management. Learning Objectives. Case 1. » Appropriate use of beta-blockers. Management of diabetes drugs

Challenges in Perioperative Medication Management. Learning Objectives. Case 1. » Appropriate use of beta-blockers. Management of diabetes drugs Challenges in Perioperative Medication Management Dimitriy Levin, MD Assistant Professor of Medicine University of Colorado Hospital Medicine Group Learning Objectives» Appropriate use of beta-blockers

More information

by Brian Wolfe, MD Assistant Professor of Medicine, University of Colorado Denver

by Brian Wolfe, MD Assistant Professor of Medicine, University of Colorado Denver Perioperative Cases by Brian Wolfe, MD Assistant Professor of Medicine, University of Colorado Denver 75 yo for left knee arthroplasty Problem List Social Hx: obesity uses a walker diabetes because of

More information

Clinical Practice Guideline for Anticoagulation Management

Clinical Practice Guideline for Anticoagulation Management Clinical Practice Guideline for Anticoagulation Management This guideline is to inform practitioners of the Standard of Care for providing safe and effective anticoagulation management for ambulatory patients.

More information

8/28/2018. Pre-op Evaluation for non cardiac surgery. A quick review from 2007!! Disclosures. John Steuter, MD. None

8/28/2018. Pre-op Evaluation for non cardiac surgery. A quick review from 2007!! Disclosures. John Steuter, MD. None Pre-op Evaluation for non cardiac surgery John Steuter, MD Disclosures None A quick review from 2007!! Fliesheret al, ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and are for Noncardiac

More information

Preoperative Management of Patients Receiving Antithrombotics

Preoperative Management of Patients Receiving Antithrombotics Preoperative Management of Patients Receiving Antithrombotics Bleeding complications remain an important concern for most surgical procedures. Attempts to minimize the risk of these complications by removing

More information

Preoperative Evaluation of Patients Undergoing Noncardiac Surgery

Preoperative Evaluation of Patients Undergoing Noncardiac Surgery Preoperative Evaluation of Patients Undergoing Noncardiac Surgery Shazia Khan, MD Assistant Professor of Clinical Medicine Keck School of Medicine LAC+USC Medical Center Learning Objectives Use a risk

More information

Case #1. 73 y/o man with h/o HTN and CHF admitted with dizziness and SOB Treated for CHF exacerbation with Lasix Now HR 136

Case #1. 73 y/o man with h/o HTN and CHF admitted with dizziness and SOB Treated for CHF exacerbation with Lasix Now HR 136 Tachycardias Case #1 73 y/o man with h/o HTN and CHF admitted with dizziness and SOB Treated for CHF exacerbation with Lasix Now HR 136 Initial Assessment Check Telemetry screen if pt on tele Telemetry

More information

Predicting Short Term Morbidity following Revision Hip and Knee Arthroplasty

Predicting Short Term Morbidity following Revision Hip and Knee Arthroplasty Predicting Short Term Morbidity following Revision Hip and Knee Arthroplasty A Review of ACS-NSQIP 2006-2012 Arjun Sebastian, M.D., Stephanie Polites, M.D., Kristine Thomsen, B.S., Elizabeth Habermann,

More information

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME

More information

ATRIAL FIBRILLATION: REVISITING CONTROVERSIES IN AN ERA OF INNOVATION

ATRIAL FIBRILLATION: REVISITING CONTROVERSIES IN AN ERA OF INNOVATION ATRIAL FIBRILLATION: REVISITING CONTROVERSIES IN AN ERA OF INNOVATION Frederick Schaller, DO, MACOI,FACP Adjunct Clinical Professor Touro University Nevada DISCLOSURES I have no financial relationships

More information

PERIOPERATIVE ANESTHETIC RISK IN THE GERIATRIC PATIENT

PERIOPERATIVE ANESTHETIC RISK IN THE GERIATRIC PATIENT PERIOPERATIVE ANESTHETIC RISK IN THE GERIATRIC PATIENT Susan H. Noorily, M.D. Clinical Professor of Anesthesiology Medical Director University Preoperative Medicine Center IMPORTANCE Half of all currently

More information

Peripheral Arterial Disease Medical Approach and Management

Peripheral Arterial Disease Medical Approach and Management Peripheral Arterial Disease Medical Approach and Management April 2, 2016 Michael F. Hagerty, MD FACC PAD: Classic and New Concepts Let s take a look at what s new and what s old or classic in 2016. PAD:

More information

Perioperative risk reduction and B-blockers. Topics. Introduction 3/26/2012

Perioperative risk reduction and B-blockers. Topics. Introduction 3/26/2012 Perioperative risk reduction and B-blockers UCSF Department of Surgery Postgraduate Course John Maa MD, FACS March 25, 2012 Topics 1) The controversy over beta blockers and POISE --- is Clonidine the answer?

More information

AMERICAN SOCIETY OF ANESTHESIOLOGISTS ANESTHESIA PRE OPERATIVE SCREENING ASA PHYSICAL STATUS CLASSIFICATION ANESTHESIOLOGISTS

AMERICAN SOCIETY OF ANESTHESIOLOGISTS ANESTHESIA PRE OPERATIVE SCREENING ASA PHYSICAL STATUS CLASSIFICATION ANESTHESIOLOGISTS ANESTHESIA PRE OPERATIVE SCREENING CAPA S 37 TH ANNUAL CONFERENCE PALM SPRINGS OCTOBER 5, 2013 ROBERT F. KOPEL, MD, FACP, FCCP HOAG HOSPITAL ASSISTANT CLINICAL PROFESSOR UCLA SCHOOL OF MEDICINE AMERICAN

More information

Pre-op Risk Assessment. Hal Blanks MD FACC

Pre-op Risk Assessment. Hal Blanks MD FACC Pre-op Risk Assessment Hal Blanks MD FACC Objectives: Identify and manage patients with known or suspected CAD and other cardiac diseases who are at risk of cardiac complications during noncardiac surgery.

More information

Medical Apps for Cardiology Uses. There s an App for That!

Medical Apps for Cardiology Uses. There s an App for That! Medical Apps for Cardiology Uses There s an App for That! Audience Participation Question #1 1. ASCVD Risk App What is the predicted 10 year CV event rate for a 57 y/o black male patient with treated

More information

Holy Crap! Why is a Cardiologist Speaking at a GI Meeting? Jonathan A. Rapp, MD, FACC, FSCAI Cardiologist, Mercy Heart Institute Cincinnati, OH

Holy Crap! Why is a Cardiologist Speaking at a GI Meeting? Jonathan A. Rapp, MD, FACC, FSCAI Cardiologist, Mercy Heart Institute Cincinnati, OH Holy Crap! Why is a Cardiologist Speaking at a GI Meeting? Jonathan A. Rapp, MD, FACC, FSCAI Cardiologist, Mercy Heart Institute Cincinnati, OH Goals and Objectives Discuss cardiac considerations for patients

More information

John V. Vanore, DPM Gadsden, AL

John V. Vanore, DPM Gadsden, AL Perioperative Considerations John V. Vanore, DPM Gadsden, AL PERIOPERATIVE MANAGEMENT J Foot Ankle Surg 2017:56:336 Goals & Objectives Anticipate & prevent complications Identify difficult or at risk patients

More information

Oral Anticoagulation Drug Class Prior Authorization Protocol

Oral Anticoagulation Drug Class Prior Authorization Protocol Oral Anticoagulation Drug Class Prior Authorization Protocol Line of Business: Medicaid P & T Approval Date: February 21, 2018 Effective Date: April 1, 2018 This policy has been developed through review

More information

HEART OF THE MATTER: cardiac issues in safe endoscopy & sedation

HEART OF THE MATTER: cardiac issues in safe endoscopy & sedation HEART OF THE MATTER: cardiac issues in safe endoscopy & sedation YUVAL KONSTANTINO M.D. CARDIOLOGY DEPARTMENT, ELECTROPHYSIOLOGY UNIT, SOROKA MEDICAL CENTER, BEN-GURION UNIVERSITY OUTLINE 1 2 3 Anticoagulation

More information

Perioperative Decision Making The decision has been made to proceed with operative management timing and site of surgery the type of anesthesia preope

Perioperative Decision Making The decision has been made to proceed with operative management timing and site of surgery the type of anesthesia preope Preoperative Evaluation In Endocrine Disorders Dr Nahid Zirak 2012 Perioperative Decision Making The decision has been made to proceed with operative management timing and site of surgery the type of anesthesia

More information

Dr Micheal Looney Consultant Anaesthetist Connolly Hospital Blanchardstown. To Delay or Not to Delay Hip Fracture Surgery

Dr Micheal Looney Consultant Anaesthetist Connolly Hospital Blanchardstown. To Delay or Not to Delay Hip Fracture Surgery Dr Micheal Looney Consultant Anaesthetist Connolly Hospital Blanchardstown To Delay or Not to Delay Hip Fracture Surgery "You may delay, but time will not, and lost time is never found again." Benjamin

More information

Anesthesia for Cardiac Patients for Non Cardiac Surgery. Kimberly Westra DNP, MSN, CRNA

Anesthesia for Cardiac Patients for Non Cardiac Surgery. Kimberly Westra DNP, MSN, CRNA Anesthesia for Cardiac Patients for Non Cardiac Surgery Kimberly Westra DNP, MSN, CRNA Anesthesia for Cardiac Patients for Non Cardiac Surgery Heart Disease is a significant problem in the United States:

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Activated partial thromboplastin time abnormality, perioperative approach to, 104 105 Acute kidney injury, perioperative, 89 99 early

More information

CARDIAC REHABILITATION PROGRAMME:- MEDICATION

CARDIAC REHABILITATION PROGRAMME:- MEDICATION CARDIAC REHABILITATION PROGRAMME:- MEDICATION AIM OF THIS SESSION Understand the reasons for taking your medications, Discuss the common side effects associated with these medications - knowing when to

More information

MENDED HEARTS An Evening with your Pharmacists

MENDED HEARTS An Evening with your Pharmacists MENDED HEARTS An Evening with your Pharmacists CHRIS MIN, PHARM D Cardiology Pharmacy Resident ANTICOAGULANTS Commonly referred to as blood thinners Used for 2 primary reasons: 1. Prevent a new clot from

More information

Documenting in the World of ICD-10 Capturing all your CCs and MCCs Crystal Coen, RN, MSN, FNP-BC NPSS Asheville, NC

Documenting in the World of ICD-10 Capturing all your CCs and MCCs Crystal Coen, RN, MSN, FNP-BC NPSS Asheville, NC Documenting in the World of ICD-10 Capturing all your CCs and MCCs Crystal Coen, RN, MSN, FNP-BC 2017 NPSS Asheville, NC Objectives Understand the importance of documenting to the highest specificity Understand

More information

Writing with purpose. Make IT real and simple. On the Medicine Wards for Medical Students, Interns, and Residents

Writing with purpose. Make IT real and simple. On the Medicine Wards for Medical Students, Interns, and Residents Writing with purpose Make IT real and simple On the Medicine Wards 2017-2018 for Medical Students, Interns, and Residents Omar S. Darwish, MS, DO Health Science Assistant Professor Coordinator of the M&M

More information

Atrial Fibrillation Version 2 11/4/15 This order set must be used with an admission order set if patient not already admitted.

Atrial Fibrillation Version 2 11/4/15 This order set must be used with an admission order set if patient not already admitted. Patient Name: Diagnosis: Allergies with reaction type: Atrial Fibrillation Version 2 11/4/15 This order set must be used with an admission order set if patient not already admitted. Telemetry Medical Telemetry:

More information

Implementation of a PSH Model in a Preoperative Clinic

Implementation of a PSH Model in a Preoperative Clinic Implementation of a PSH Model in a Preoperative Clinic Les Garson, MD Department of Anesthesiology & Perioperative Care June 27, 2015 Key points for a PSH Pre Op Clinic Culture Change Management Triage

More information

Updates & Controversies in Perioperative Medicine

Updates & Controversies in Perioperative Medicine Updates in Perioperative Medicine Updates & Controversies in Perioperative Medicine Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco New Guidelines for Perioperative

More information

Timing of Surgery After Percutaneous Coronary Intervention

Timing of Surgery After Percutaneous Coronary Intervention Timing of Surgery After Percutaneous Coronary Intervention Deepak Talreja, MD, FACC Bayview/EVMS/Sentara Outline/Highlights Timing of elective surgery What to do with medications Stopping anti-platelet

More information

Perioperative Anticoagulation Management

Perioperative Anticoagulation Management Perioperative Anticoagulation Management ACP Delaware Chapter Scientific Meeting Feb 9, 2019 Andrew Dunn, MD, MPH, MACP Chief, Division of Hospital Medicine Mount Sinai Health System, NY DISCLOSURES Desai

More information

12 Lead ECG Workshop. Virginia Hass, DNP, FNP-C, PA-C Kim Newlin, CNS, ANP-C, FPCNA. California Association of Nurse Practitioners March 18, 2016

12 Lead ECG Workshop. Virginia Hass, DNP, FNP-C, PA-C Kim Newlin, CNS, ANP-C, FPCNA. California Association of Nurse Practitioners March 18, 2016 12 Lead ECG Workshop Virginia Hass, DNP, FNP-C, PA-C Kim Newlin, CNS, ANP-C, FPCNA California Association of Nurse Practitioners March 18, 2016 Learning Objectives Identify key changes on the ECG which

More information

Drug Class Monograph

Drug Class Monograph Drug Class Monograph Class: Oral Anticoagulants Drug: Coumadin (warfarin), Eliquis (apixaban), Pradaxa (dabigatran), Savaysa (edoxaban), arelto (rivaroxaban) Formulary Medications: Eliquis (apixaban),

More information

Difficult to Treat Hypertension

Difficult to Treat Hypertension Difficult to Treat Hypertension According to Goldilocks JNC 8 Blood Pressure Goals (2014) BP Goal 60 years old and greater*- systolic < 150 and diastolic < 90. (Grade A)** BP Goal 18-59 years old* diastolic

More information

Dysrhythmias 11/7/2017. Disclosures. 3 reasons to evaluate and treat dysrhythmias. None. Eliminate symptoms and improve hemodynamics

Dysrhythmias 11/7/2017. Disclosures. 3 reasons to evaluate and treat dysrhythmias. None. Eliminate symptoms and improve hemodynamics Dysrhythmias CYDNEY STEWART MD, FACC NOVEMBER 3, 2017 Disclosures None 3 reasons to evaluate and treat dysrhythmias Eliminate symptoms and improve hemodynamics Prevent imminent death/hemodynamic compromise

More information

Afib, Stroke, and DOAC. Albert Luo, MD. Cardiology Lindsey Frischmann, DO. Neurology Xiao Cai, MD. HBS

Afib, Stroke, and DOAC. Albert Luo, MD. Cardiology Lindsey Frischmann, DO. Neurology Xiao Cai, MD. HBS Afib, Stroke, and DOAC Albert Luo, MD. Cardiology Lindsey Frischmann, DO. Neurology Xiao Cai, MD. HBS Disclosure of Relevant Financial Relationships I have no relevant financial relationships with commercial

More information

Cost and Prevalence of A fib. Atrial Fibrillation: Guideline Directed Treatment. Prevalence of A Fib. Risk Factors for A Fib. Risk Factors for A Fib

Cost and Prevalence of A fib. Atrial Fibrillation: Guideline Directed Treatment. Prevalence of A Fib. Risk Factors for A Fib. Risk Factors for A Fib Atrial Fibrillation: Guideline Directed Treatment Melissa Wendell, FNP-C, MSN Heart Failure - Lead Nurse Practitioner, Aspirus Wausau Hospital and Aspirus Cardiology Cost and Prevalence of A fib 33.5 million

More information

Antithrombotics 201: Aspirin and USPSTF. Presented by: Craig Williams, PharmD., BCPS., FNLA; November, Conflicts of Interest: None

Antithrombotics 201: Aspirin and USPSTF. Presented by: Craig Williams, PharmD., BCPS., FNLA; November, Conflicts of Interest: None Antithrombotics 201: Aspirin and USPSTF Presented by: Craig Williams, PharmD., BCPS., FNLA; November, 2016 Conflicts of Interest: None 1 What percent of patients who die within 30 days of an MI die before

More information

Prescribe appropriate immunizations for. Prescribe childhood immunization as per. Prescribe influenza vaccinations in high-risk

Prescribe appropriate immunizations for. Prescribe childhood immunization as per. Prescribe influenza vaccinations in high-risk Supplemental Digital Appendix 1 46 Health Care Problems and the Corresponding 59 Practice Indicators Expected of All Physicians Entering or in Practice Infectious and parasitic diseases Avoidable complications/death

More information

Let s Gi e The So ethi g To Clot About: Controversies in Anticoagulation

Let s Gi e The So ethi g To Clot About: Controversies in Anticoagulation Let s Gi e The So ethi g To Clot About: Controversies in Anticoagulation Janna Beavers, MS, PharmD, BCPS Cardiology Clinical Pharmacy Specialist WakeMed Health & Hospitals Raleigh, NC March 13, 2018 Pharmacist

More information

2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants

2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants 2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants Wednesday, May 9, 2018, 12:00PM ET Guest Author: Adam Cuker, MD Presenter: Tracy Minichiello, MD

More information

Beta Blockade. Andre P. Marshall, PGY2 8/14/09 VANDERBILT SURGERY

Beta Blockade. Andre P. Marshall, PGY2 8/14/09 VANDERBILT SURGERY Beta Blockade Andre P. Marshall, PGY2 8/14/09 Beta Blockade Who are the Betas anyway? When, why, and how do we block them? The Beta Receptor B 1 : cardiac chronotropic and inotropic B 2 : bronchodilation,

More information

Perioperative Assessment in the Older Adult. Sondra Vazirani, MD, MPH

Perioperative Assessment in the Older Adult. Sondra Vazirani, MD, MPH Perioperative Assessment in the Older Adult Sondra Vazirani, MD, MPH The Preoperative Evaluation in the Older Adult Sondra Vazirani, MD, MPH, FACP* 33 rd UCLA Intensive Course in Geriatric Medicine & Pharmacy,

More information

Challenging Anticoagulation Case Studies. Earl J. Hope, M.D. Tower Health Cardiology

Challenging Anticoagulation Case Studies. Earl J. Hope, M.D. Tower Health Cardiology Challenging Anticoagulation Case Studies Earl J. Hope, M.D. Tower Health Cardiology Financial Disclosures Nothing to disclose Objectives: 1. Understand indications for heparin bridging. 2. Recognize the

More information

Intrinsic + Common = aptt. Extrinsic + Common = PT. Common Pathway

Intrinsic + Common = aptt. Extrinsic + Common = PT. Common Pathway Anticoagulant Cases 12 11 Intrinsic + Common = aptt 9 8 10 7 4 Extrinsic + Common = PT 5 2 Common Pathway 1 Xa Inhibitors rivaroxaban (Xarelto) apixaban (Eliquis) edoxaban (Savaysa) What is true regarding

More information

HIP ATTACK Trial: Can we improve outcomes after a hip fracture with accelerated surgery? PJ Devereaux, MD, PhD

HIP ATTACK Trial: Can we improve outcomes after a hip fracture with accelerated surgery? PJ Devereaux, MD, PhD HIP ATTACK Trial: Can we improve outcomes after a hip fracture with accelerated surgery? PJ Devereaux, MD, PhD Disclosure Member of research group with policy of not accepting honorariums or other payments

More information

Disclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None

Disclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None Disclosures DVT: Diagnosis and Treatment None Susanna Shin, MD, FACS Assistant Professor University of Washington Acute Venous Thromboembolism (VTE) Deep Venous Thrombosis (DVT) Pulmonary Embolism (PE)

More information

Cardiovascular Pharmacotherapy Update

Cardiovascular Pharmacotherapy Update Cardiovascular Pharmacotherapy Update Debby Caraballo, PharmD, PhC, BCPS April 30 th 2011 Objectives Review recent updates in cardiovascular pharmacotherapy Discuss the updates to Afib, UA/NSTEMI, STEMI/PCI

More information

Medical Treatment for acute Decompensated Heart Failure. Vlasis Ninios Cardiologist St. Luke s s Hospital Thessaloniki 2011

Medical Treatment for acute Decompensated Heart Failure. Vlasis Ninios Cardiologist St. Luke s s Hospital Thessaloniki 2011 Medical Treatment for acute Decompensated Heart Failure Vlasis Ninios Cardiologist St. Luke s s Hospital Thessaloniki 2011 2010 HFSA guidelines for ADHF 2009 focused update of the 2005 American College

More information

Nothing to Disclose. Severe Pulmonary Hypertension

Nothing to Disclose. Severe Pulmonary Hypertension Severe Ronald Pearl, MD, PhD Professor and Chair Department of Anesthesiology Stanford University Rpearl@stanford.edu Nothing to Disclose 65 year old female Elective knee surgery NYHA Class 3 Aortic stenosis

More information

The Role of Oral Anticoagulants in Atrial Fibrillation: What You Need to Know Now. Bradley A. Hardin, MD Richard F.

The Role of Oral Anticoagulants in Atrial Fibrillation: What You Need to Know Now. Bradley A. Hardin, MD Richard F. The Role of Oral Anticoagulants in Atrial Fibrillation: What You Need to Know Now Bradley A. Hardin, MD Richard F. Otten, MD, FACC Outline Atrial Fibrillation Overview Overview of New Oral Anticoagulants

More information

Preoperative Risk. Geoffrey C Zarrella DO FACC. Assessment

Preoperative Risk. Geoffrey C Zarrella DO FACC. Assessment Preoperative Risk Geoffrey C Zarrella DO FACC Assessment your late add ons keep calm use your tools stick to your guns PURPOSE OF THE PREOP EVAL ASSESS PERIOP RISK CAN INFORM DECISION TO PROCEED OR

More information

3/25/2017. Program Outline. Classification of Atrial Fibrillation

3/25/2017. Program Outline. Classification of Atrial Fibrillation Alternate Strategies to Antiarrhythmic Therapy: The Role of Ablation Jennifer El Aile, MS, AGPCNP-BC Electrophysiology Nurse Practitioner Clinical Lecturer at the University of Michigan Program Outline

More information

Challenges in Anticoagulation and Thromboembolism

Challenges in Anticoagulation and Thromboembolism Challenges in Anticoagulation and Thromboembolism Ethan Cumbler M.D. Assistant Professor of Medicine Hospitalist Medicine Section University of Colorado Denver May 2010 No Conflicts of Interest Objectives

More information

Diabetes: Use of Adjunctive Therapy ACEs, ARBs, ASA & STATINs --Oh My! Veronica J. Brady, PhD, FNP-BC, BC-ADM, CDE Project ECHO April 19, 2018

Diabetes: Use of Adjunctive Therapy ACEs, ARBs, ASA & STATINs --Oh My! Veronica J. Brady, PhD, FNP-BC, BC-ADM, CDE Project ECHO April 19, 2018 Diabetes: Use of Adjunctive Therapy ACEs, ARBs, ASA & STATINs --Oh My! Veronica J. Brady, PhD, FNP-BC, BC-ADM, CDE Project ECHO April 19, 2018 Points to Ponder ASCVD is the leading cause of morbidity

More information

Treatment of the Medically Compromised Patient

Treatment of the Medically Compromised Patient Treatment of the Medically Compromised Patient Nashville Area Continuing Dental Education Series November 3, 2010 Harry J. Brown, MD Chief Medical Officer, Nashville Area Outline General Principles Specific

More information

Dr Ben Edwards Consultant Anaesthetist Sheffield Teaching Hospitals

Dr Ben Edwards Consultant Anaesthetist Sheffield Teaching Hospitals Dr Ben Edwards Consultant Anaesthetist Sheffield Teaching Hospitals 70-75,000 #NOF per annum (costs 2 billion) 10% die within 1 month 33% die within 1 year Operative delays >48hs more than doubles risk

More information

Diagnosis: Allergies with reaction type:

Diagnosis: Allergies with reaction type: Patient Name: Diagnosis: Allergies with reaction type: ICU Stroke-Ischemic S/P tpa Version 2 5/29/14 This order set is designed to be used with an admission set or for a patient already admitted Nursing

More information

Orthopedic Surgery for Adults with Cerebral Palsy- Medical Considerations. Disclosures. Objectives. Adults with Cerebral Palsy

Orthopedic Surgery for Adults with Cerebral Palsy- Medical Considerations. Disclosures. Objectives. Adults with Cerebral Palsy Orthopedic Surgery for Adults with Cerebral Palsy- Medical Considerations American Academy for Cerebral Palsy and Developmental Medicine, 2013, IC 6 Garey Noritz, MD, FAAP, FACP Nationwide Children s Hospital

More information

VanderbiltEM.com. Atrial Fibrillation Update Don t Miss a Beat ACEP AFib. 20 Facts on Atrial Fibrillation in 20 minutes

VanderbiltEM.com. Atrial Fibrillation Update Don t Miss a Beat ACEP AFib. 20 Facts on Atrial Fibrillation in 20 minutes Atrial Fibrillation Update Don t Miss a Beat ACEP 2015 Corey M. Slovis, M.D. Vanderbilt University Medical Center Metro Nashville Fire Department Nashville International Airport Nashville, TN VanderbiltEM.com

More information

Form 1: Demographics

Form 1: Demographics Form 1: Demographics Case Number: *LMRN: *DOB: / / *Gender: Male Female *Race: White Native Hawaiian/Other Pacific Islander Black or African American Asian American Indian or Alaska Native Unknown *Hispanic

More information

Challenges in Anticoagulation Bridging and Emerging Therapies. Disclosures and Relationships. Objectives. Dr. Cumbler has no conflicts of interest

Challenges in Anticoagulation Bridging and Emerging Therapies. Disclosures and Relationships. Objectives. Dr. Cumbler has no conflicts of interest Challenges in Anticoagulation Bridging and Emerging Therapies Ethan Cumbler MD FACP Associate Professor of Medicine Hospitalist Medicine Section University of Colorado Denver 2011 Disclosures and Relationships

More information

Beta Blockade: Protection or Panacea

Beta Blockade: Protection or Panacea Beta Blockade: Protection or Panacea Jason Axt Jason s Recommendations Perioperative β Blockade (BB) If on BB stay on If Vascular Sx + documented ischemia - start. 2+ risk factors - start Use in isolated

More information

2015 Atrial Fibrillation Therapy Meds, Shock, or Ablate? D. Scott Kirby MD, FACC Cardiac Electrophysiologist

2015 Atrial Fibrillation Therapy Meds, Shock, or Ablate? D. Scott Kirby MD, FACC Cardiac Electrophysiologist 2015 Atrial Fibrillation Therapy Meds, Shock, or Ablate? D. Scott Kirby MD, FACC Cardiac Electrophysiologist Todays Objectives Atrial Fibrillation evaluation and treatment from an EP perspective Multimodal

More information

An Overview of Perioperative Medicine 2014: From Outpatient Preoperative Assessment to Inpatient Postoperative Care

An Overview of Perioperative Medicine 2014: From Outpatient Preoperative Assessment to Inpatient Postoperative Care An Overview of Perioperative Medicine 2014: From Outpatient Preoperative Assessment to Inpatient Postoperative Care WEDNESDAY, OCTOBER 22, 2014 6:00 a.m. Continental Breakfast and Registration 7:30 a.m.

More information

Direct Oral Anticoagulants An Update

Direct Oral Anticoagulants An Update Oct. 26, 2017 Direct Oral Anticoagulants An Update Kathleen Heintz, DO, FACC Assistant Professor of Medicine Cooper Heart Institute Direct Oral Anticoagulants: DISCLAIMERS No Conflicts of Interest So what

More information

Preoperative Pulmonary Evaluation. Michelle Zetoony, DO, FCCP, FACOI Board Certified Pulmonary, Critical Care, Sleep and Internal Medicine

Preoperative Pulmonary Evaluation. Michelle Zetoony, DO, FCCP, FACOI Board Certified Pulmonary, Critical Care, Sleep and Internal Medicine Preoperative Pulmonary Evaluation Michelle Zetoony, DO, FCCP, FACOI Board Certified Pulmonary, Critical Care, Sleep and Internal Medicine No disclosures related to this lecture. Objectives Identify pulmonary

More information